These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 20175406

  • 1. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 2. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.
    Sleep; 2003 Nov 01; 26(7):793-9. PubMed ID: 14655910
    [Abstract] [Full Text] [Related]

  • 3. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 01; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 5. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.
    Arch Gen Psychiatry; 2008 May 01; 65(5):551-62. PubMed ID: 18458207
    [Abstract] [Full Text] [Related]

  • 6. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
    Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T.
    Sleep; 2007 Aug 01; 30(8):959-68. PubMed ID: 17702264
    [Abstract] [Full Text] [Related]

  • 7. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
    Scharf M, Erman M, Rosenberg R, Seiden D, McCall WV, Amato D, Wessel TC.
    Sleep; 2005 Jun 01; 28(6):720-7. PubMed ID: 16477959
    [Abstract] [Full Text] [Related]

  • 8. A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.
    Krystal AD, Huang H, Zummo J, Grinnell T, Marshall RD.
    Sleep Med; 2012 Jun 01; 13(6):691-6. PubMed ID: 22465450
    [Abstract] [Full Text] [Related]

  • 9. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Liang L, Huang Y, Xu R, Wei Y, Xiao L, Wang G.
    Sleep Med; 2019 Oct 01; 62():6-13. PubMed ID: 31518944
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A, Fava M, Rubens R, Wessel T, Caron J, Wilson P, Roth T, McCall WV.
    J Clin Sleep Med; 2007 Feb 15; 3(1):48-55. PubMed ID: 17557453
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.
    Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T.
    Curr Med Res Opin; 2004 Dec 15; 20(12):1979-91. PubMed ID: 15701215
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL, McAllister PJ, Bilchik TR.
    Cranio; 2015 Apr 15; 33(2):115-21. PubMed ID: 25323219
    [Abstract] [Full Text] [Related]

  • 13. Eszopiclone: a review of its use in the treatment of insomnia.
    Hair PI, McCormack PL, Curran MP.
    Drugs; 2008 Apr 15; 68(10):1415-34. PubMed ID: 18578559
    [Abstract] [Full Text] [Related]

  • 14. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK.
    J Clin Sleep Med; 2008 Jun 15; 4(3):229-34. PubMed ID: 18595435
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.
    Goforth HW, Preud'homme XA, Krystal AD.
    Sleep; 2014 Jun 01; 37(6):1053-60. PubMed ID: 24882900
    [Abstract] [Full Text] [Related]

  • 16. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC.
    J Clin Psychiatry; 2011 Apr 01; 72(4):473-9. PubMed ID: 21208574
    [Abstract] [Full Text] [Related]

  • 17. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N, Kamijo A, Kuwahara H, Uchiyama M, Shimizu T, Chiba S, Inoue Y.
    Sleep Med; 2012 Dec 01; 13(10):1247-53. PubMed ID: 23063301
    [Abstract] [Full Text] [Related]

  • 18. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
    Tek C, Palmese LB, Krystal AD, Srihari VH, DeGeorge PC, Reutenauer EL, Guloksuz S.
    Schizophr Res; 2014 Dec 01; 160(1-3):180-5. PubMed ID: 25454802
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
    Fietze I, Bassetti CLA, Mayleben DW, Pain S, Seboek Kinter D, McCall WV.
    Drugs Aging; 2022 Oct 01; 39(10):795-810. PubMed ID: 36098936
    [Abstract] [Full Text] [Related]

  • 20. Eszopiclone for insomnia.
    Rösner S, Englbrecht C, Wehrle R, Hajak G, Soyka M.
    Cochrane Database Syst Rev; 2018 Oct 10; 10(10):CD010703. PubMed ID: 30303519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.